Chronic lithium administration ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats; potential role for adenosine triphosphate sensitive potassium channels

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 7, 2011, Pages 1174-1181

  Daneshmand, Ali ^a   Mohammadi, Hamed ^a   Rahimian, Reza ^a   Habibollahi, Peiman ^a   Fakhfouri, Gohar ^b   Talab, Saman Shafat ^a   Mehr, Shahram Ejtemaei ^a   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

2, 4, 6 trinitrobenzene sulfonic acid; Inflammatory bowel disease; Lithium; Potassium channel

Indexed keywords

CROMAKALIM; GLIBENCLAMIDE; LITHIUM CHLORIDE; MALONALDEHYDE; MYELOPEROXIDASE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; ENTERITIS; EXPERIMENTAL MODEL; LITHIUM BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RAT;

EID: 79958783190     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06719.x     Document Type: Article

References (46)

1. Brown SJ, Mayer L. The immune response in inflammatory bowel disease. Am. J. Gastroenterol. 2007; 102: 2058-69.
2. Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J. Pharmacol. Toxicol. Methods 2004; 50: 81-92.
3. Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm. Bowel Dis. 2003; 9: 179-89.
4. Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 2000; 51: 289-98.
5. Szanto I, Rubbia-Brand L, Kiss P etal. Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J. Pathol. 2005; 207: 164-76.
6. Krieglstein CF, Cerwinka WH, Laroux FS etal. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J. Exp. Med. 2001; 194: 1207-18.
7. Wei XM, Heywood GJ, Di Girolamo N, Thomas PS. Nicorandil inhibits the release of TNFalpha from a lymphocyte cell line and peripheral blood lymphocytes. Int. Immunopharmacol. 2003; 3: 1581-8.
8. Hosseini-Tabatabaei A, Esamily H, Rahimian R etal. Benefit of nicorandil using an immunologic murine model of experimental colitis. Cent. Eur. J. Biol. 2009; 4: 74-85.
9. Wood AJJ, Price LH, Heninger GR. Lithium in the treatment of mood disorders. N. Engl. J. Med. 1994; 331: 591-8.
10. Lieb J. Lithium and immune function. Med. Hypotheses 1987; 23: 73-93.
11. Gallicchio VS, Cibull ML, Hughes NK, Tse KF. Effect of lithium in murine immunodeficiency virus infected animals. Pathobiology 1993; 61: 216-21.
12. Lenz SP, Izui S, Benediktsson H, Hart DA. Lithium chloride enhances survival of NZB/W lupus mice: influence of melatonin and timing of treatment. Int. J. Immunopharmacol. 1995; 17: 581-92.
13. Daneshmand A, Rahimian R, Mohammadi H etal. Protective effects of lithium on acetic acid-induced colitis in rats. Dig. Dis. Sci. 2009; 54: 1901-7.
14. Allison JH, Blisner ME, Holland WH, Hipps PP. Increased brain-inositol 1-phosphate in lithium-treated rats. Biochem. Biophys. Res. Commun. 1976; 71: 664-70.
15. Williams RSB, Harwood AJ. Lithium therapy and signal transduction. Trends Pharmacol. Sci. 2000; 21: 61-4.
16. Newman ME, Belmaker RH. Effects of lithium in vitro and ex vivo on components of the adenylate cyclase system in membranes from the cerebral cortex of the rat. Neuropharmacology 1987; 26: 211-17.
17. Mørk A, Geisler A. The effects of lithium in vitro and ex vivo on adenylate cyclase in brain are exerted by distinct mechanisms. Neuropharmacology 1989; 28: 307-11.
18. Peskar BM, Ehrlich K, Peskar BA. Role of ATP-sensitive potassium channels in prostaglandin-mediated gastroprotection in the rat. J. Pharmacol. Exp. Ther. 2002; 301: 969-74.
19. Mourelle M, Vilaseca J, Guarner F, Salas A, Malagelada JR. Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase. Am. J. Physiol. 1996; 270 (3 Pt 1): G425-30.
20. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
21. Mustafa A, El-Medany A, Hagar HH, El-Medany G. Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis. Pharmacol. Res. 2006; 53: 324-30.
22. Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am. J. Physiol. 1990; 258 (4 Pt 1): G527-34.
23. Boirivant M, Fuss IJ, Chu A, Strober W. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. 1998; 188: 1929-39.
24. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 1982; 78: 206-9.
25. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979; 95: 351-8.
26. Reinecker HC, Steffen M, Witthoeft T. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 1993; 94: 174-81.
27. Dehpour AR, Sadr SS, Nouroddini M. Comparison of simultaneous administration of lithium with L-NAME or L-arginine on morphine withdrawal syndrome in mice. Hum. Psychopharmacol. 2000; 15: 87-93.
28. Kasper D, Fauci AS, Braunwald E etal. Harrison's Principles of Internal Medicine, Vol. 2. New York: McGraw-Hill, 2005.
29. Sturgess NC, Ashford ML, Cook DL, Hales CN. The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet 1985; 2: 474-5.
30. Quast U. Do the K+ channel openers relax smooth muscle by opening K+ channels? Trends Pharmacol. Sci. 1993; 14: 332-7.
31. Kolgazi M, Jahovic N, Yuksel M, Ercan F, Alican I. Alpha-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats. J. Gastroenterol. Hepatol. 2007; 22: 1859-65.
32. Appleyard CB, Wallace JL. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am. J. Physiol. Gastrointest. Liver Physiol. 1995; 269: G119-25.
33. Zhu F, Qian J, Pan G. The establishment of TNBS-induced experimental colitis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1998; 20: 271-8.
34. Masoodi I, Kochhar R, Dutta U etal. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis. J. Gastroenterol. Hepatol. 2009; 24: 1768-74.
35. McConnico RS, Weinstock D, Poston ME, Roberts MC. Myeloperoxidase activity of the large intestine in an equine model of acute colitis. Am. J. Vet. Res. 1999; 60: 807-13.
36. Gomez-Estrada H, Hernandez-Delgado J, Diaz-Esquivel P. Decreased myeloperoxidase activity of mice polymorphonuclear leukocytes by lithium carbonate treatment. Arch. Invest. Med. (Mex) 1984; 15: 287-91.
37. Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig. Dis. Sci. 2007; 52: 2015-21.
38. Kinoshita K, Hori M, Fujisawa M etal. Role of TNF-alpha in muscularis inflammation and motility disorder in a TNBS-induced colitis model: clues from TNF-alpha-deficient mice. Neurogastroenterol. Motil. 2006; 18: 578-88.
39. Shen C, de Hertog G, Bullens DM etal. Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization? Inflamm. Bowel Dis. 2007; 13: 308-16.
40. Lauritzen I, De Weille JR, Lazdunski M. The potassium channel opener (-)-cromakalim prevents glutamate-induced cell death in hippocampal neurons. J. Neurochem. 1997; 69: 1570-9.
41. Liu Y, O'Rourke B. Opening of mitochondrial K(ATP) channels triggers cardioprotection. Are reactive oxygen species involved? Circ. Res. 2001; 88: 750-2.
42. Hosseini-Tabatabaei A, Abdollahi M. Potassium channel openers and improvement of toxic stress: do they have role in the management of inflammatory bowel disease? Inflamm. Allergy Drug Targets 2008; 7: 129-35.
43. Kawamura T, Kadosaki M, Nara N, Wei J, Endo S, Inada K. Nicorandil attenuates NF-kappaB activation, adhesion molecule expression, and cytokine production in patients with coronary artery bypass surgery. Shock 2005; 24: 103-8.
44. Akar F, Uydes-Dogan BS, Buharalioglu CK etal. Protective effect of cromakalim and diazoxide, and proulcerogenic effect of glibenclamide on indomethacin-induced gastric injury. Eur. J. Pharmacol. 1999; 374: 461-70.
45. Abdel-Zaher AO. The myoneural effects of lithium chloride on the nerve-muscle preparations of rats. Role of adenosine triphosphate-sensitive potassium channels. Pharmacol. Res. 2000; 41: 163-78.
46. Li HR, Qin CQ, Zhang ZH, Zhu JC, Liu Y. Stimulation effect of lithium on the metabolic activity of liver tissue mitochondria measured by microcalorimetry. Biol. Trace Elem. Res. 2006; 114: 163-73.